ATE393780T1 - Reinigungsverfahren zur grossmassstabigen produktion von gc-globulin, damit erhaltenes produkt und dessen verwendung in medizin - Google Patents

Reinigungsverfahren zur grossmassstabigen produktion von gc-globulin, damit erhaltenes produkt und dessen verwendung in medizin

Info

Publication number
ATE393780T1
ATE393780T1 AT02754557T AT02754557T ATE393780T1 AT E393780 T1 ATE393780 T1 AT E393780T1 AT 02754557 T AT02754557 T AT 02754557T AT 02754557 T AT02754557 T AT 02754557T AT E393780 T1 ATE393780 T1 AT E393780T1
Authority
AT
Austria
Prior art keywords
globulin
medicine
scale production
purification process
product
Prior art date
Application number
AT02754557T
Other languages
English (en)
Inventor
Charlotte Svaerke Jorgensen
Inga Laursen
Gunnar Houen
Original Assignee
Statens Seruminstitut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Statens Seruminstitut filed Critical Statens Seruminstitut
Application granted granted Critical
Publication of ATE393780T1 publication Critical patent/ATE393780T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Obesity (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT02754557T 2001-08-14 2002-08-12 Reinigungsverfahren zur grossmassstabigen produktion von gc-globulin, damit erhaltenes produkt und dessen verwendung in medizin ATE393780T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200101217 2001-08-14

Publications (1)

Publication Number Publication Date
ATE393780T1 true ATE393780T1 (de) 2008-05-15

Family

ID=8160667

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02754557T ATE393780T1 (de) 2001-08-14 2002-08-12 Reinigungsverfahren zur grossmassstabigen produktion von gc-globulin, damit erhaltenes produkt und dessen verwendung in medizin

Country Status (9)

Country Link
EP (1) EP1419177B1 (de)
JP (1) JP2005508892A (de)
AT (1) ATE393780T1 (de)
AU (1) AU2002321012B2 (de)
CA (1) CA2456843A1 (de)
DE (1) DE60226327T2 (de)
DK (1) DK1419177T3 (de)
ES (1) ES2305272T3 (de)
WO (1) WO2003016348A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2411959C2 (ru) * 2004-06-29 2011-02-20 Релайанс Лайф Сайенсиз Пвт Лтд Способ получения безопасных в вирусном отношении биологических текучих сред
CN100354301C (zh) * 2005-10-13 2007-12-12 南京工业大学 化学合成多肽的新型大规模分离制备技术
US8129139B2 (en) * 2009-07-13 2012-03-06 Allergan, Inc. Process for obtaining botulinum neurotoxin
SG10201503899SA (en) * 2010-05-18 2015-06-29 Abbvie Inc Apparatus And Process Of Purification Of Proteins
JP5860401B2 (ja) 2010-09-03 2016-02-16 森田薬品工業株式会社 新規Ｇｃグロブリンガラクトース脱糖体の製造方法
EP2682168A1 (de) 2012-07-02 2014-01-08 Millipore Corporation Reinigung biologischer Moleküle
WO2015087981A1 (ja) * 2013-12-13 2015-06-18 医療法人再生未来 ウシ初乳酵素処理物、その製造方法、組成物および飲食品
CN106456813B (zh) * 2014-04-15 2020-06-30 勃林格殷格翰国际公司 在制造生物制品期间连续灭活病毒的方法、装置和系统
WO2016194914A1 (ja) * 2015-06-01 2016-12-08 再生ファーマ株式会社 乳酵素処理物、その製造方法、組成物および製品

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5177002A (en) * 1989-11-20 1993-01-05 Nobuto Yamamoto In vitro enzymatic conversion of glycosylated human vitamin D binding protein to a potent macrophage activating factor
DK0526544T3 (da) * 1990-04-11 1999-06-21 Brigham & Womens Hospital Terapeutiske anvendelser af actinbindende forbindelser
US6268478B1 (en) * 1996-02-12 2001-07-31 Cedars-Sinai Medical Center Intracellular vitamin D binding protein

Also Published As

Publication number Publication date
JP2005508892A (ja) 2005-04-07
EP1419177B1 (de) 2008-04-30
ES2305272T3 (es) 2008-11-01
CA2456843A1 (en) 2003-02-27
EP1419177A2 (de) 2004-05-19
DE60226327T2 (de) 2009-07-09
WO2003016348A3 (en) 2004-03-04
AU2002321012B2 (en) 2008-07-24
DK1419177T3 (da) 2008-08-25
DE60226327D1 (de) 2008-06-12
WO2003016348A2 (en) 2003-02-27

Similar Documents

Publication Publication Date Title
US10005823B2 (en) Peptides having effects on promoting wound healing, collagen production, angiogenesis, activation of immunocytes and applications thereof
EP2270511A3 (de) Therapieverfahren
ATE393780T1 (de) Reinigungsverfahren zur grossmassstabigen produktion von gc-globulin, damit erhaltenes produkt und dessen verwendung in medizin
ATE209684T1 (de) Dna-sequenzen für matrix-metallproteasen, ihre herstellung und verwendung
ATE121424T1 (de) Hpth-fragment-(1-37), seine herstellung, dieses enthaltende arzneimittel und seine verwendung.
YU73301A (sh) eNOS MUTACIJE,NJIHOVA UPOTREBA ZA PRIPREMU LEKA ZA GENSKU TERAPIJU I POSTUPCI TERAPEUTSKOG SKRININGA
Chen et al. Adjustable parameters and the effectiveness of adjunct robot-assisted gait training in individuals with chronic stroke
FI953565A7 (fi) Uusi antikoagulanttikofaktoriaktiivisuus
DE3914869C1 (de)
AU678343B2 (en) Method and composition for determining the immunological activity of bioactive substances
Di Sarno et al. Intranasal human-recombinant nerve growth factor enhances motor and cognitive function recovery in a child with severe traumatic brain injury
Ferrara et al. Pilot study on the effect of biophysical therapy on salivary alpha-amylase as a surrogate measure of anxiety/stress: in search of a novel noninvasive molecular approach for the management of stress
Zhang et al. Electroacupuncture promotes nerve regeneration and functional recovery in rats with spinal cord contusion through the coordinate interaction of CD4 and BDNF
WO2001064240A3 (en) Methods for promoting production of myelin by schwann cells
Arfors et al. Variations in the serum esterases of humans, apes and monkeys
JPS6041615A (ja) コロニ−形成刺激因子の製造方法
CN104560925A (zh) 一种从人凝血因子ⅸ层析废液中激活制备人凝血酶的方法
CN103789291A (zh) 一种重组大肠杆菌发酵液中分离纯化重组人尿激酶原的制备工艺
HRP20140247T1 (hr) Cjepivo protiv raka
Jeon et al. Investigating effects of negative emotional states on the korean elderly's osteoarthritis prevalence
Le et al. Selenium in Biological Fluids in the Bodies of Patients with Associated Trauma
RU2489172C1 (ru) Способ проведения лечебного дискретного плазмафереза с экстракарпоральной модификацией эритроцитов и лейкоцитов индукторами интерферона, антиоксидантами и протекторами клеток
Vasiuk et al. Selenium in Biological Fluids in the Bodies of Patients with Associated Trauma
PH22020050168U3 (en) Process for isolating and producing antibodies for the prevention and treatment of covid-19 and related diseases from blood plasma containing said antibodies
Ravliv et al. Investigation of the amino acid composition of tablets on the basis of cryolophilized xenoderm of pigs

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties